Biohit Oyj (BIOBV):企業の財務・戦略的SWOT分析

◆英語タイトル:Biohit Oyj (BIOBV) - Financial and Strategic SWOT Analysis Review
◆商品コード:DATA904C14530
◆発行会社(調査会社):GlobalData
◆発行日:2019年3月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:フィンランド
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD300 ⇒換算¥44,400見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD600 ⇒換算¥88,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD900 ⇒換算¥133,200見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Biohit Oyj (Biohit) is a biotechnology company that offers research and early diagnosis processing products. The company’s products comprise acetaldehyde binding products, diagnostic tests, dysbiosis test, microplate readers and washers, monoclonal antibodies, and pipettes. It targets therapeutic areas such as gastric cancer, gastroesophageal reflux disease and colorectal cancer, among others. Biohit provides analyses of non-alcoholic and alcoholic beverages and carcinogenic acetaldehyde in foodstuff. The company promotes evaluation and adoption of Biohit’s diagnostic tests and analysing systems. It also offers tests for the diagnosis of lactose intolerance and helicobacter pylori infection. The company operates in Finland, Italy and the UK. Biohit is headquartered in Helsinki, Finland.

Biohit Oyj Key Recent Developments

Feb 20,2019: Biohit group financial statement release 2018
Jan 31,2019: Business Development Director Lea Paloheimo will retire from Biohit Oyj
Dec 31,2018: Chief Medical Director Kari Syrjanen will retire from Biohit Oyj
Oct 16,2018: Stina Syrjanen resigns from Biohit Oyj’s Board of Directors

This comprehensive SWOT profile of Biohit Oyj provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Biohit Oyj including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

Biohit Oyj – Key Information
Biohit Oyj – Overview
Biohit Oyj – Key Employees
Biohit Oyj – Key Employee Biographies
Biohit Oyj – Key Operational Heads
Biohit Oyj – Major Products and Services
Biohit Oyj – History
Biohit Oyj – Company Statement
Biohit Oyj – Locations And Subsidiaries
Biohit Oyj – Key Manufacturing facilities
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

Biohit Oyj – Business Description
Biohit Oyj – Corporate Strategy
Biohit Oyj – SWOT Analysis
SWOT Analysis – Overview
Biohit Oyj – Strengths
Biohit Oyj – Weaknesses
Biohit Oyj – Opportunities
Biohit Oyj – Threats
Biohit Oyj – Key Competitors

Section 3 – Company Financial Performance Charts

Biohit Oyj – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

Biohit Oyj, Key Information
Biohit Oyj, Key Ratios
Biohit Oyj, Share Data
Biohit Oyj, Major Products and Services
Biohit Oyj, History
Biohit Oyj, Key Employees
Biohit Oyj, Key Employee Biographies
Biohit Oyj, Key Operational Heads
Biohit Oyj, Other Locations
Biohit Oyj, Subsidiaries
Biohit Oyj, Key Manufacturing facilities
Biohit Oyj, Key Competitors
Biohit Oyj, SWOT Analysis
Biohit Oyj, Ratios based on current share price
Biohit Oyj, Annual Ratios
Biohit Oyj, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures

Biohit Oyj, Performance Chart
Biohit Oyj, Ratio Charts

★海外企業調査レポート[Biohit Oyj (BIOBV):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • VirnetX Holding Corp (VHC):企業の財務・戦略的SWOT分析
    Summary VirnetX Holding Corp (VirnetX) is a technology company that provides software and technology solutions for securing real-time communications. The company provides a gabriel connection technology which is an OEM software development kit, and is designed to secure real time communications over …
  • Midatech Pharma US Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Midatech Pharma US Inc (Midatech Pharma), formerly DARA BioSciences, Inc., is a pharmaceutical company which focuses on the development and commercialization of cancer treatment and supportive care products. It is a subsidiary of Midatech Pharma Plc. The company’s product portfolio includes …
  • Thai Union Frozen Products Public Company Limited:企業の戦略・SWOT・財務情報
    Thai Union Frozen Products Public Company Limited - Strategy, SWOT and Corporate Finance Report Summary Thai Union Frozen Products Public Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structur …
  • Close Brothers Group Plc:企業の戦略・SWOT・財務情報
    Close Brothers Group Plc - Strategy, SWOT and Corporate Finance Report Summary Close Brothers Group Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Medifocus Inc (MFS):医療機器:M&Aディール及び事業提携情報
    Summary Medifocus Inc (Medifocus) is a medical technology company. The company develops and commercializes minimally invasive focused heat systems for the treatment of cancerous and benign tumors, and enlarged prostate. Its technology platforms includes endo-thermotherapy platform, a catheter-based …
  • QBE Insurance (Vietnam) Company Ltd:企業の戦略的SWOT分析
    QBE Insurance (Vietnam) Company Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major …
  • Hsh Nordbank Private Banking
    Hsh Nordbank Private Banking - Strategy, SWOT and Corporate Finance Report Summary Hsh Nordbank Private Banking - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Pacific Drilling SA (PACD):企業の財務・戦略的SWOT分析
    Summary Pacific Drilling SA (Pacific Drilling) is an offshore drilling company that offers ultra deepwater drilling services to the oil and natural gas industry. The company provides contract services for floating rig drilling in ultra deepwater through its drill ships. It rents its drilling rigs, r …
  • Adisseo France SAS:企業の戦略的SWOT分析
    Adisseo France SAS - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and ser …
  • OraSure Technologies Inc (OSUR):医療機器:M&Aディール及び事業提携情報
    Summary OraSure Technologies Inc (OraSure) is a manufacturer and distributor of oral fluid specimen collection devices, diagnostic products and other medical devices. Its product portfolio encompasses infectious disease tests for the detection of antibodies for the HIV and Hepatitis C virus; Ebola v …
  • Recylex SA:企業の戦略・SWOT・財務情報
    Recylex SA - Strategy, SWOT and Corporate Finance Report Summary Recylex SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Spire Inc (SR):企業の財務・戦略的SWOT分析
    Spire Inc (SR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the po …
  • 23andMe Inc:医療機器:M&Aディール及び事業提携情報
    Summary 23andMe Inc (23andMe) is a biotechnology research and information provider that offers tools for health and ancestry care. The company offers raw genetic data and ancestry-related genetic reports. Its service portfolio includes clinical development, research and development, ancestry service …
  • Purdue Pharma LP-製薬・医療分野:企業M&A・提携分析
    Summary Purdue Pharma LP (Purdue) is a privately held, US-based pharmaceutical company which develops pharmacologic therapies for the treatment and management of pain. The company undertakes the research, development, manufacture and marketing of prescription medicines and over-the-counter (OTC) med …
  • Quidel Corp (QDEL)-医療機器分野:企業M&A・提携分析
    Summary Quidel Corp (Quidel) develops, manufactures and markets rapid diagnostic testing solutions for the detection and diagnosis of critical diseases and other medical conditions. Its major products include immunoassays; molecular assays; virology products including traditional cell lines, specime …
  • Scania AB:企業の戦略・SWOT・財務情報
    Scania AB - Strategy, SWOT and Corporate Finance Report Summary Scania AB - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • Chiyoda Corporation (6366)-石油・ガス分野:企業M&A・提携分析
    Summary Chiyoda Corporation (Chiyoda) is an engineering services provider that offers various services along with its subsidiaries. Its offerings include project management, program management, feasibility studies, front end engineering design works, engineering, procurement, construction, commissio …
  • Rockwool International AS:戦略・SWOT・企業財務分析
    Rockwool International AS - Strategy, SWOT and Corporate Finance Report Summary Rockwool International AS - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Elasmogen Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Elasmogen Ltd (Elasmogen), formerly Pacific Shelf 1760 Ltd is a biopharmaceutical company that discovers and develops sight-saving therapies for the treatment of inflammatory diseases of the eye and inflammatory conditions of the gut. The company develops soloMER that are small (11 kDa) and …
  • Swagelok Company:企業の戦略・SWOT・財務情報
    Swagelok Company - Strategy, SWOT and Corporate Finance Report Summary Swagelok Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆